75 related articles for article (PubMed ID: 6255571)
1. [Prevention and treatment of recurrences of myocardial infarction. Results in 2026 patients monitored for 44 months in a group study].
Sem Hop; 1980 Oct 18-25; 56(39-40):1575-7. PubMed ID: 6255571
[No Abstract] [Full Text] [Related]
2. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
3. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
[No Abstract] [Full Text] [Related]
4. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
[No Abstract] [Full Text] [Related]
5. [Results of prevention of second myocardial infarct with syncumar or aspirin].
Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
[No Abstract] [Full Text] [Related]
6. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
7. Use of dipyridamole in patients with recent stroke or TIA.
Bernstein RA
Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
[No Abstract] [Full Text] [Related]
8. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
[No Abstract] [Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
11. Three large-scale clinical trials of aspirin in the USA.
Krol WF
Proc R Soc Med; 1977; 70 Suppl 7(Suppl 7):24-7. PubMed ID: 353816
[No Abstract] [Full Text] [Related]
12. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
Vyshlov EV; Panfilova EV; Markov VA
Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
[TBL] [Abstract][Full Text] [Related]
13. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
14. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
[TBL] [Abstract][Full Text] [Related]
15. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
[TBL] [Abstract][Full Text] [Related]
16. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
17. [Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
Caneschi S; Bonaventi C; Finzi F
Minerva Med; 1985 Oct; 76(41):1933-43. PubMed ID: 2865702
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).
Pamukcu B; Oflaz H; Onur I; Oncul A; Ozcan M; Umman B; Mercanoglu F; Meric M; Nisanci Y
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):187-92. PubMed ID: 17287637
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
20. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
